Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Download references

Open Access

No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial

Robert Eggertsen*, Åke Andreasson and Lennart Andrén

BMC Pharmacology and Toxicology 2012, 13:10  doi:10.1186/2050-6511-13-10

Include


Format